Clinical Trial Update: Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome. [NA]

View source ↗

Summary

A clinical trial evaluating low-dose growth hormone treatment for metabolic syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Metabolic Syndrome | NA | Status: WITHDRAWN